The University of Chicago Header Logo

Connection

Mark Talamonti to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Treatment Outcome.
Mark Talamonti
Connection Strength
1.056
Treatment Outcome
  1. Endovascular management of portal vein obstruction in hepatobiliary cancer patients. J Surg Oncol. 2022 Mar; 125(3):392-398.
    View in: PubMed
    Score: 0.084
  2. Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience. Expert Opin Biol Ther. 2020 01; 20(1):95-104.
    View in: PubMed
    Score: 0.074
  3. Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients. Br J Dermatol. 2017 Aug; 177(2):489-496.
    View in: PubMed
    Score: 0.063
  4. Brodalumab for the treatment of psoriasis. Expert Rev Clin Immunol. 2016 Dec; 12(12):1255-1271.
    View in: PubMed
    Score: 0.060
  5. Defining quality for distal pancreatectomy: does the laparoscopic approach protect patients from poor quality outcomes? J Gastrointest Surg. 2013 Feb; 17(2):273-80.
    View in: PubMed
    Score: 0.046
  6. Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. Dermatology. 2011; 222(3):250-5.
    View in: PubMed
    Score: 0.041
  7. Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. Am J Surg. 2011 Mar; 201(3):295-9; discussion 299-300.
    View in: PubMed
    Score: 0.040
  8. The effects of bevacizumab on postoperative complications in patients undergoing colorectal and pancreatic cancer resection. J Surg Oncol. 2010 Oct 01; 102(5):539-42.
    View in: PubMed
    Score: 0.039
  9. Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals. Am J Surg. 2007 Nov; 194(5):588-93.
    View in: PubMed
    Score: 0.032
  10. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007 Oct; 142(4):529-34; discussion 534-7.
    View in: PubMed
    Score: 0.032
  11. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg. 2007 Mar; 193(3):389-93; discussion 393-4.
    View in: PubMed
    Score: 0.031
  12. Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience. Am J Surg. 2006 Mar; 191(3):437-41.
    View in: PubMed
    Score: 0.029
  13. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol. 2006 Feb; 13(2):150-8.
    View in: PubMed
    Score: 0.028
  14. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
    View in: PubMed
    Score: 0.024
  15. Robotic Pancreaticoduodenectomy for Intraductal Papilary Mucinous Neoplasm in a Patient post Roux-en-Y Gastric Bypass. Obes Surg. 2023 04; 33(4):1309-1310.
    View in: PubMed
    Score: 0.023
  16. Risk factors and outcomes in patients undergoing minimally invasive hepatectomy with unplanned conversion: a contemporary NSQIP analysis. HPB (Oxford). 2023 05; 25(5):577-588.
    View in: PubMed
    Score: 0.023
  17. Bile leak incidence, risk factors and associated outcomes in patients undergoing hepatectomy: a contemporary NSQIP propensity matched analysis. Surg Endosc. 2022 08; 36(8):5710-5723.
    View in: PubMed
    Score: 0.022
  18. Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching. J Surg Oncol. 2020 Aug; 122(2):183-194.
    View in: PubMed
    Score: 0.019
  19. Variation in Hospital Utilization of Minimally Invasive Distal Pancreatectomy for Localized Pancreatic Neoplasms. J Gastrointest Surg. 2020 12; 24(12):2780-2788.
    View in: PubMed
    Score: 0.018
  20. Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene: results from a multicentre study of four European psoriasis cohorts. J Eur Acad Dermatol Venereol. 2020 Jan; 34(1):112-118.
    View in: PubMed
    Score: 0.018
  21. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Surgery. 2018 03; 163(3):582-586.
    View in: PubMed
    Score: 0.016
  22. The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy. HPB (Oxford). 2018 02; 20(2):140-146.
    View in: PubMed
    Score: 0.016
  23. Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
    View in: PubMed
    Score: 0.016
  24. Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy. J Gastrointest Surg. 2017 Oct; 21(10):1620-1625.
    View in: PubMed
    Score: 0.016
  25. Minimally invasive pancreatic resections: cost and value perspectives. HPB (Oxford). 2017 03; 19(3):225-233.
    View in: PubMed
    Score: 0.015
  26. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy. Ann Surg. 2016 Oct; 264(4):640-9.
    View in: PubMed
    Score: 0.015
  27. Management of ductal carcinoma in situ. Semin Surg Oncol. 1996 Sep-Oct; 12(5):300-13.
    View in: PubMed
    Score: 0.015
  28. Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base. J Am Coll Surg. 2015 Jul; 221(1):175-84.
    View in: PubMed
    Score: 0.013
  29. Pancreatic cancer and FOLFIRINOX: a new era and new questions. Cancer Med. 2015 Jun; 4(6):853-63.
    View in: PubMed
    Score: 0.013
  30. The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes. Am J Surg. 2015 Mar; 209(3):557-63.
    View in: PubMed
    Score: 0.013
  31. Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study. J Gastrointest Surg. 2013 Jan; 17(1):94-100; discussion p. 100-1.
    View in: PubMed
    Score: 0.011
  32. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):189-98.
    View in: PubMed
    Score: 0.010
  33. The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab. Dermatology. 2010; 221 Suppl 1:43-7.
    View in: PubMed
    Score: 0.010
  34. Risk-based selective referral for cancer surgery: a potential strategy to improve perioperative outcomes. Ann Surg. 2010 Apr; 251(4):708-16.
    View in: PubMed
    Score: 0.009
  35. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg. 2009 Sep; 13(9):1692-8.
    View in: PubMed
    Score: 0.009
  36. Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers. Dermatology. 2009; 219(1):48-53.
    View in: PubMed
    Score: 0.009
  37. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 2008 Dec; 12(12):2078-86.
    View in: PubMed
    Score: 0.009
  38. Sociodemographic and tumor characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol. 2008 Jun 01; 97(7):578-82.
    View in: PubMed
    Score: 0.008
  39. The oblique rectus abdominal myocutaneous flap for complex pelvic wound reconstruction. Dis Colon Rectum. 2008 Aug; 51(8):1237-41.
    View in: PubMed
    Score: 0.008
  40. Squamous cell carcinoma of the anal canal: utilization and outcomes of recommended treatment in the United States. Ann Surg Oncol. 2008 Jul; 15(7):1948-58.
    View in: PubMed
    Score: 0.008
  41. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. Radiology. 2008 May; 247(2):507-15.
    View in: PubMed
    Score: 0.008
  42. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008 Mar; 247(3):490-500.
    View in: PubMed
    Score: 0.008
  43. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20; 26(6):942-7.
    View in: PubMed
    Score: 0.008
  44. Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2007 Nov; 5(10):998-1033.
    View in: PubMed
    Score: 0.008
  45. Impact of adjuvant radiation on survival: a note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol. 2007 Dec; 14(12):3321-7.
    View in: PubMed
    Score: 0.008
  46. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007 Sep; 246(3):375-81; discussion 381-4.
    View in: PubMed
    Score: 0.008
  47. Long-term treatment of plaque psoriasis with efalizumab: an Italian experience. Br J Dermatol. 2007 Apr; 156 Suppl 2:17-23.
    View in: PubMed
    Score: 0.008
  48. Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management. Surgery. 2000 Oct; 128(4):604-12.
    View in: PubMed
    Score: 0.005
  49. Results of gastric interposition for reconstruction of the pharyngoesophagus. Surgery. 1999 Oct; 126(4):666-71; discussion 671-2.
    View in: PubMed
    Score: 0.005
  50. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 1998 Apr 01; 82(7):1250-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.